Reem Ghinnagow, Julie de Meester, Luis Javier Cruz, Caroline Aspord, Stephanie Corgnac, et al.. Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses.
OncoImmunology, Taylor & Francis, 2017, 6 (9), pp.e1339855.
⟨10.1080/2162402X.2017.1339855⟩.
⟨inserm-02436029⟩